Preparation and characterization of vanillin-chitosan Schiff base zinc complex for a novel Zn2+ sustained released system.

In this work, a novel sustained released system (VCSB-Zn(II)) for zinc supplements was built by vanillin-chitosan Schiff base (VCSB) chelated with Zn2+ to improve the zinc trace element utilization ratio. Samples were characterized by FT-IR, 1H NMR, XRD, SEM, and TGA. The results showed that VCSB exhibited a more excellent chelation capacity of Zn2+ than chitosan. The chelation capacity of VCSB was about 1.7 times more than that of chitosan, corresponding to 50.96 mg/g and 29.91 mg/g, respectively. Furthermore, VCSB-Zn(II) showed excellent sustained released performance at simulated gastric fluid because of the acid slow-dissolving ability. And the higher the CN content of VCSB, the higher the cumulative release rate (Ri) of Zn2+, the highest Ri reached 77.81%. The sustained released curves were described by the first-order and Korsmeyer-Peppas equation, which described the Zn2+ sustained released performance caused by the dissolution of VCSB-Zn(II) and Fick diffusion. This Zn2+ sustained released system shows great potential in the application in the field of trace elements supplements for animals.

Assessment of biological activities of chitosan Schiff base tagged with medicinal plants.

A chitosan Schiff base with an aromatic aldehyde was synthesized and characterized by FTIR and NMR spectroscopies. Furthermore, the degree of substitution was calculated based on the ratios of the area of the proton of the imine (Aimine ) and the area of the peak of the proton of the pyranose ring (AH-2 ). The antimicrobial activities were determined against bacterial and fungal strains, as well as multiple drug-resistant (MDR) bacteria. The chitosan Schiff base was also tagged with medicinal plants, for example, Curcuma longa, Peganum harmala, Lepidium sativam, and cruciferous vegetables, and the biological activities determined against pathogenic bacterial and fungal strains. The chitosan Schiff base showed maximum zone of inhibition of 22 mm against Staphylococcus aureus with a minimum zone of inhibition of 15 mm against Bacillus cereus. The chitosan Schiff base was fused with C longa, isothiocyanates and a combined mixture of P harmala and L sativam that has shown activities against Escherichia coli with a zone of inhibition of 28, 24, and 30 mm, respectively. The Schiff base of chitosan fused with medicinal plants also showed significant inhibitory activities against MDR bacteria.